Cardiff Oncology (CRDF)
(Real Time Quote from BATS)
$4.09 USD
-0.09 (-2.15%)
Updated Apr 25, 2024 12:36 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Earnings News For CRDF
-
Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates
-
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
-
Cardiff Oncology: Q3 Earnings Snapshot
-
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q2 Earnings Snapshot
-
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
-
Cardiff Oncology: Q1 Earnings Snapshot
-
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
-
Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates
-
Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q3 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q3 Earnings Snapshot
-
Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates
-
Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q2 Earnings Snapshot
-
Cardiff Oncology Reports Second Quarter 2022 Results and Provides Business Updates
-
Cardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Cardiff Oncology (CRDF) Reports Q1 Loss, Misses Revenue Estimates
-
Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates
-
Cardiff Oncology (CRDF) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
Cardiff Oncology (CRDF) Reports Q3 Loss, Tops Revenue Estimates
-
Will Cardiff Oncology (CRDF) Report Negative Q3 Earnings? What You Should Know
-
Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates